Upregulation of the brain renin-angiotensin system in rats with chronic renal failure

Acta Physiologica

Volumn 189, Issue 4, 2007, Pages 369-377

  Nishimura, M ^a,d   Takahashi, H ^b   Yoshimura, M ^c  

^a Toujinkai Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d Toujinkai Hospital   (Japan)

Author keywords

Brain; Chronic renal failure; Hypertension; Rat; Renin angiotensin system; Sympathetic activity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BRAIN STEM; CHRONIC KIDNEY FAILURE; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART RATE; HYPERTENSION; HYPOTHALAMUS; MALE; NEPHRECTOMY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RHIZOTOMY; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BLOOD PRESSURE; BRAIN; BRAIN STEM; DISEASE MODELS, ANIMAL; HEART RATE; HYPOTHALAMUS; INFUSIONS, PARENTERAL; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; NOREPINEPHRINE; RATS; RATS, INBRED SHR; RENIN-ANGIOTENSIN SYSTEM; RHIZOTOMY; RNA, MESSENGER; TETRAZOLES; UP-REGULATION;

EID: 33947214402     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2006.01663.x     Document Type: Article

References (30)

1. Anderson, S. & Brenner, B.M. 1995. The role of nephron mass and of intraglomerular pressure in initiation and progression of experimental hypertensive-renal disorders. In: J.H. Laragh & B.M. Brenner (eds) Hypertension; Pathophysiology, Diagnosis and Management, pp. 1553-1568. Raven Press, New York.
2. Baltatu, O., Silva, J.A. Jr, Ganten, D. & Bader, M. 2000. The brain rennin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy. Hypertension 35[part 2], 409-412.
3. Calaresu, F.R. & Ciriello, J. 1981. Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in cat. J Auton Nerv Syst 3, 311-320.
4. Campese, V.M. & Kogosove, E. 1995. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25, 878-882.
5. Ciriello, J. & Calaresu, F.R. 1983. Central projection of afferent renal fibers in the rat: an anterograde transport study of horseradish peroxidase. J Auton Nerv Syst 8, 273-285.
6. Converse R.L, Jr, Jacobsen, T.N., Toto, R.D., et al. 1992. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327, 1912-1918.
7. Ferrario, C.M., Gildenberg, P.L. & McCubbin, J.W. 1972. Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res 30, 257-262.
8. Gehlert, D.R., Gackenheimer, S.L. & Schober, D.A. 1991. Autoradiographic localization of subtypes of angiotensin II antagonist binding in the brain. Neuroscience 44, 501-514.
9. Hausberg, M., Kosch, M., Harmelink, P., et al. 2002. Sympathetic nerve activity in end-stage renal disease. Circulation 106, 1974-1979.
10. Kanazawa, M., Kohzuki, M., Kurosawa, H., et al. 2004. Renoprotective effect of angiotensin-converting enzyme inhibitor combined with a1-adrenergic antagonist in spontaneously hypertensive rats with renal ablation. Hypertensive Res 27, 509-515.
11. Ligtenberg, G., Blankestijn, P.J., Oey, P.L., et al. 1999. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340, 1321-1328.
12. Makita, N., Iwai, N., Inagami, T. & Badr, K.F. 1992. Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem Biophys Res Commnun 185, 142-146.
13. Metsarinne, K.P., Helin, K.H., Saijonmaa, O., Stewen, P., Sirvio, M.L. & Fyhrquist, F.Y. 1996. Tissue-specific regulation of angiotensin-converting enzyme by angiotensin II and losartan in the rat. Blood Press 5, 363-370.
14. Milsted, A., Nishimura, M., Brosnihan, K.B. & Ferrario, C.M. 1996. Differential regulation of angiotensinogen transcripts after renin infusion. Hypertension 28, 678-681.
15. Nanbu, A., Nishimura, M., Takahashi, H., Ohtsuka, K., Sakamoto, M. & Yoshimura, M. 1998. Lower than normal expression of brain nitric oxide synthase gene in the hypothalamus of deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 16, 495-502.
16. Nishimura, M., Nanbu, A., Ohtsuka, K., et al. 1997. Sodium intake regulates renin gene expression differently in the hypothalamus and kidney of rats. J Hypertens 15, 509-516.
17. +-induced hypertension in rats. Am J Physiol 274, R635-R644.
18. Nishimura, M., Ohtsuka, K., Sakamoto, M., Nanbu, A., Takahashi, H. & Yoshimura, M. 1998b. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. J Hypertens 16, 1175-1185.
19. Nishimura, M., Ohtsuka, K., Iwai, N., Takahashi, H. & Yoshimura, M. 1999. Regulation of brain renin-angiotensin system by benzamil-blockable sodium channels. Am J Physiol 276, R1416-R1424.
20. Nishimura, M., Ohtsuka, K., Takahashi, H. & Yoshimura, M. 2000. Role of FMRFamide-activated brain sodium channel in salt-sensitive hypertension. Hypertension 35 (Suppl 1), 443-450.
21. Okada, H., Suzuki, H., Kanno, Y., Ikenaga, H. & Saruta, T. 1995. Renal responses to angiotensin receptor antagonist and angiotensin converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats. J Cardiovasc Pharmacol 26, 564-569.
22. Pupilli, C., Chevalier, R.L., Carey, R.M. & Gomez, R.A. 1992. Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol 263, F731-F738.
23. Raij, L., Chiou, X., Owens, R. & Wrigley, B. 1985. Therapeutic implications of hypertension-induced glomerular injury: comparison of enarapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model. Am J Med 79, 37-41.
24. Rump, L.C. 1999. Advantages of Ang-II receptor blockade over ACE inhibition with respect to suppression of sympathetic activity: heartening news for the kidney? Nephrol Dial Transplant 14, 556-559.
25. Tsutsumi, K. & Saavedra, J.M. 1991. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 261, R209-R216.
26. Wang, H., Huang, B.S., Ganten, D. & Leenen, F.H.H. 2004. Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ Res 94, 843-849.
27. Wolf, G., Thaiss, F., Mueller, E., et al. 1995. Glomerular mRNA expression of angiotensinase A after renal ablation. Exp Nephrol 3, 240-248.
28. Wyss, J.M. & Donovan, M.K. 1984. A direct projection from the kidney to the brainstem. Brain Res 298, 130-134.
29. Ye, S., Zhong, H., Duong, V.N. & Campese, V.M. 2002. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 39, 1101-1106.
30. Zoccali, C., Mallamaci, F., Parlongo, S., et al. 2002. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105, 1354-1359.